Injective (INJ) shows signs of recovery after bouncing off a key support level at $9.30. Analysis indicates that this level supports core buyer activity.
Technical Analysis of INJ and Support Levels
Injective (INJ) shows recovery after bouncing off the $9.30 level. Crypto analyst Crypto Tony noted that this level previously acted as resistance in early 2023 but has now turned into support. The quick recovery from a recent dip below $9.30 signifies bullish sentiment among buyers.
Drop in Futures Open Interest
Data from CoinGlass shows that INJ's futures open interest has sharply declined, even as the token's price recovers. Open interest, which peaked at over $300 million in March 2025, has now fallen below $30 million. This marks a substantial decline in speculative activity, indicating lower participation from derivatives traders.
Launch of Tokenized U.S. Equities on Helix
Injective has launched on-chain versions of leading U.S. stocks, including Apple, Microsoft, Amazon, and Netflix. This announcement was made during the Injective NYC Summit held on June 26. The new assets are available through the Helix exchange and use the iAsset framework.
The launch of tokenized equities and the price recovery of INJ demonstrate the active development of the Injective platform. It is essential to monitor further market changes and traders' reactions to these initiatives.
